Zacks Screens Four GARP Stocks With Strong Growth and Value Metrics

Industry
โดย Zacks Investment Research·Read original
Summary · why it matters

Zacks Investment Research identified four stocks that passed its growth-at-a-reasonable-price screen: Tapestry, Vertiv, Celestica, and Cencora. The screen required a Zacks Rank of 1 or 2, five-year historical and projected EPS growth of 10% to 25%, return on equity above the industry average, and price-to-earnings and price-to-book ratios below the industry average. Tapestry raised its fiscal 2026 revenue outlook to roughly $7.95 billion and saw its consensus earnings estimate rise 7.8% to $6.95 per share over the past 60 days. Vertiv lifted its 2026 guidance to net sales of $13.5 to $14 billion and adjusted EPS of $6.30 to $6.40, with its consensus estimate up 5.6% to $6.36. Celestica raised its full-year 2026 outlook to $19.0 billion in revenue and $10.15 in adjusted EPS, and its consensus estimate climbed 13.6% to $10.16. Cencora revised its fiscal 2026 adjusted EPS guidance to $17.70 to $17.90, and its consensus estimate edged up 0.8% to $17.72.

Impact on stocks 4

Health Care · 1 stocks
Cencora Inc.
COR
▲ PositiveCapitalrelevance

Cencora revised its fiscal 2026 adjusted EPS guidance upward, and consensus estimate rose.

Consumer Discretionary · 1 stocks
Tapestry Inc
TPR
▲ PositiveCapitalrelevance

Tapestry raised its fiscal 2026 revenue outlook and consensus earnings estimate increased.

Artificial Intelligence · 1 stocks
Vertiv Holdings Co
VRT
▲ PositiveCapitalrelevance

Vertiv lifted its 2026 guidance for net sales and adjusted EPS, with consensus estimate up.

Information Technology · 1 stocks